In NEW020, Boston Biomedica Acquires BioSeq, moved earlier today, we are advised by the company that the third graph, second line should read "...transfer agreement with Biomolecular Assays Inc. d/b/a/ BMA Labs (Woburn Mass.)," rather than "...transfer agreement with Biomolecular Applications" as originally issued.
